IRIS
DE FERRARI, GAETANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.029
AS - Asia 5.626
EU - Europa 3.639
SA - Sud America 1.140
Continente sconosciuto - Info sul continente non disponibili 324
AF - Africa 192
OC - Oceania 8
Totale 17.958
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.806
CN - Cina 2.859
SG - Singapore 1.127
IE - Irlanda 1.030
BR - Brasile 866
VN - Vietnam 621
HK - Hong Kong 472
RU - Federazione Russa 454
DE - Germania 433
IT - Italia 411
FI - Finlandia 358
UA - Ucraina 234
FR - Francia 232
GB - Regno Unito 160
IN - India 128
CA - Canada 125
SE - Svezia 111
AR - Argentina 106
ZA - Sudafrica 95
BD - Bangladesh 70
AT - Austria 63
MX - Messico 50
ID - Indonesia 48
EC - Ecuador 46
IQ - Iraq 46
PK - Pakistan 41
CO - Colombia 39
JP - Giappone 39
PL - Polonia 30
VE - Venezuela 28
NL - Olanda 24
PY - Paraguay 23
TR - Turchia 22
BE - Belgio 21
MY - Malesia 21
ES - Italia 20
MA - Marocco 19
SA - Arabia Saudita 18
KE - Kenya 17
CL - Cile 15
UZ - Uzbekistan 15
JM - Giamaica 14
EG - Egitto 13
PH - Filippine 12
TN - Tunisia 12
AE - Emirati Arabi Uniti 10
DZ - Algeria 9
JO - Giordania 9
AL - Albania 8
AZ - Azerbaigian 8
CR - Costa Rica 8
AU - Australia 7
UY - Uruguay 7
IL - Israele 6
PE - Perù 6
TH - Thailandia 6
BG - Bulgaria 5
KZ - Kazakistan 5
MU - Mauritius 5
PT - Portogallo 5
RO - Romania 5
AO - Angola 4
BH - Bahrain 4
CH - Svizzera 4
DO - Repubblica Dominicana 4
KW - Kuwait 4
LT - Lituania 4
NP - Nepal 4
PR - Porto Rico 4
PS - Palestinian Territory 4
QA - Qatar 4
TT - Trinidad e Tobago 4
BA - Bosnia-Erzegovina 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
EU - Europa 3
GE - Georgia 3
GR - Grecia 3
GT - Guatemala 3
IR - Iran 3
KR - Corea 3
LB - Libano 3
LV - Lettonia 3
OM - Oman 3
BW - Botswana 2
CG - Congo 2
CI - Costa d'Avorio 2
CY - Cipro 2
EE - Estonia 2
ET - Etiopia 2
HN - Honduras 2
HU - Ungheria 2
MN - Mongolia 2
MQ - Martinica 2
NG - Nigeria 2
PA - Panama 2
SI - Slovenia 2
SN - Senegal 2
SR - Suriname 2
SV - El Salvador 2
Totale 17.615
Salva come PNG Salva come JPEG
Città #
Dublin 1.028
Chandler 746
Nanjing 655
Ashburn 652
San Jose 633
Jacksonville 597
Dallas 544
Singapore 544
Hong Kong 460
Beijing 433
Council Bluffs 285
Nanchang 261
Boardman 247
Ho Chi Minh City 220
Princeton 206
Lawrence 198
Medford 190
Changsha 187
Lauterbourg 177
Shenyang 174
Wilmington 174
Los Angeles 163
Helsinki 162
Hebei 155
Hanoi 154
Jiaxing 145
New York 127
Munich 121
Hangzhou 112
Tianjin 106
Moscow 89
Buffalo 88
São Paulo 82
Pavia 79
Ann Arbor 77
Johannesburg 73
Redondo Beach 72
Santa Clara 61
Shanghai 60
Nuremberg 54
Mcallen 52
Milan 49
Orem 43
Norwalk 39
Montréal 37
Tokyo 36
Dearborn 33
Fairfield 33
Woodbridge 33
Frankfurt am Main 30
Vienna 30
Atlanta 28
Rio de Janeiro 28
Guangzhou 27
Warsaw 27
Turku 25
Haiphong 24
Seattle 23
Brooklyn 21
Chennai 21
Chicago 21
Da Nang 20
Montreal 20
Ottawa 20
Toronto 20
Biên Hòa 19
Brasília 19
Curitiba 19
Baghdad 18
San Francisco 18
Verona 18
Brussels 17
Jinan 17
Joinville 17
Mexico City 17
Rome 17
Denver 16
Phoenix 16
Stockholm 16
Columbus 15
Quito 15
Zhengzhou 15
Des Moines 14
Guayaquil 14
Jakarta 14
Pune 14
Redwood City 14
Tashkent 14
Buenos Aires 13
Mumbai 13
Bari 12
Dhaka 12
Manchester 12
Nairobi 12
New Delhi 12
Boston 11
Caracas 11
Falkenstein 11
Houston 11
Kunming 11
Totale 11.845
Salva come PNG Salva come JPEG
Nome #
Vagus nerve stimulation: from pre-clinical to clinical application: challenges and future directions. 254
Identificazione di microRNA circolanti specificatamente sovra espressi in corso di infarto miocardico acuto. 253
Amiodarone 175
Pathophysiological rationale for cardiac vagal denervation in the treatment of atrial fibrillation 171
Antidepressants: their effects on cardiac channels, QT prolongation and Torsade de Pointes 169
A challenging case of permanent junctional reciprocating tachycardia (pjrt) in post-partum cardiogenic shock 148
Closure of patent foramen ovale or medical therapy alone for secondary prevention of cryptogenic cerebrovascular events 148
PREDESTINATION: PRimary vEntricular fibrillation and suDden dEath during a firST myocardIal iNfArcTION: Genetic basis. 144
Gene symbol: KCNH2 141
Comparison of Outcomes of Staged Complete Revascularization Versus Culprit Lesion–Only Revascularization for ST-Elevation Myocardial Infarction and Multivessel Coronary Artery Disease 136
Atrial arrhythmias prevalence in heart transplant patients. 135
Past and future of the "Pavia eCPR program" 131
[Vagus nerve stimulation for the treatment of heart failure] 130
Patient Outcomes With STEMI Caused by Aneurysmal Coronary Artery Disease and Treated With Primary PCI 129
Clinical governance programme in patients with acute coronary syndrome: Design and methodology of a quality improvement initiative 129
Autonomic mechanisms and sudden death. New insights from analysis of baroreceptor reflexes in conscious dogs with and without a myocardial infarction. 128
Remote ischemic postconditioning as a strategy to reduce acute kidney injury during primary PCI: A post-hoc analysis of a randomized trial 126
Amiodarone in the treatment of Atrial Fibrillation: New Perspectives from Clinical Trials 125
Antithrombotic strategies in the catheterization laboratory for patients with acute coronary syndromes undergoing percutaneous coronary interventions: Insights from the EmploYEd antithrombotic therapies in patients with acute coronary Syndromes HOspitalized in Italian cardiac care units Registry 124
Elevated serum uric acid affects myocardial reperfusion and infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention 122
Angiography- versus physiology-guided complete revascularization in patients with STEMI and multivessel disease: who's the better gatekeeper in this setting? 122
Atherothrombotic Risk Stratification and the Efficacy and Safety of Vorapaxar in Patients with Stable Ischemic Heart Disease and Previous Myocardial Infarction 120
Efficacy versus safety: The dilemma of using novel platelet inhibitors for the treatment of patients with ischemic stroke and coronary artery disease 120
Smoker's paradox in ST-elevation myocardial infarction: Role of inflammation and platelets 120
Elucidating arrhythmogenic mechanisms of long-QT syndrome CALM1-F142L mutation in patient-specific induced pluripotent stem cell-derived cardiomyocytes 118
Strategies for reducing door to balloon time in patients with acute myocardial infarction undergoing primary angioplasty: the Pavia experience 117
Favorable effect of glycoprotein IIbIIIa inhibitors among STEMI patients treated with primary PCI and incomplete ST resolution 116
[Baroceptive reflex sensibility in non-anesthetized animals. Evaluation and comparison of 2 methods applicable to humans]. 115
Acute Kidney Injury Definition and In-Hospital Mortality in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction 114
Drug eluting stents are superior to bare metal stents to reduce clinical outcome and stent-related complications in CKD patients, a systematic review, meta-analysis and network meta-analysis 114
Prognostic Impact of in-Hospital-Bleeding in Patients With ST-Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention 113
[Sudden death after myocardial infarction. Prediction based on the baroreceptor reflex]. 112
Autonomic nervous system, myocardial ischemia, and malignant ventricular arrhythmias: Experimental findings 112
The prognostic value of late gadolinium enhancement in hypertrophic cardiomyopathy: An updated meta-analysis 112
Successful repair of lateral wall pseudoaneurysm via left anterior minithoracotomy using port-access tecnique 111
Baroreflex sensitivity predicts long-term cardiovascular mortality after myocardial infarction even in patients with preserved left ventricular function. 111
Autonomic Modulation for the Management of Patients with Chronic Heart Failure 111
Ranolazine in the treatment of atrial fibrillation: Results of the dose-ranging RAFFAELLO (ranolazine in atrial fibrillation following an electrical cardioversion) study 110
Atrial fibrillation in heart failure patients: prevalence in daily practice and effect on the severity of symptoms. Data from the ALPHA study registry. 109
Clinical Benefit of Evolocumab by Severity and Extent of Coronary Artery Disease: An Analysis from FOURIER. 109
KCNH2-K897T Is a Genetic Modifier of Latent Congenital Long-QT Syndrome. 108
Thromboembolism after atrioventricular node ablation and pacing: long term follow up. 108
Autonomic nervous system and arrhythmias. 107
Baroreceptor reflexes and sudden cardiac death: experimental findings and background. 107
Dual versus triple therapy in patients on oral anticoagulants and undergoing coronary stent implantation: A systematic review and meta-analysis 107
End-tidal carbon dioxide and defibrillation success in out-of-hospital cardiac arrest 106
Atrial fibrillation requiring urgent medical care. Approach and outcome in the various departments of admission. Data from the atrial Fibrillation/flutter Italian REgistry (FIRE). 106
KCNH2-K897T is a genetic modifier of latent congenital long-QT syndrome. 104
Bortezomib-induced cardiogenic shock in a multiple myeloma patient with K light-chain cardiac amyloidosis 102
Scopolamine increases vagal tone and vagal reflexes in patients after myocardial infarction 102
Leptin affects the inflammatory response after STEMI 101
Scopolamine increases vagal tone and vagal reflexes in patients after myocardial infarction. 100
Arterial baroreflexes and ventricular tachycardia. 100
Response to Letters Regarding Article, "Clinical Management of Catecholaminergic Polymorphic Ventricular Tachycardia: The Role of Left Cardiac Sympathetic Denervation" 100
Rapid recovery of baroreceptor reflexes in acute myocardial infarction is a marker of effective tissue reperfusion 99
Risk factors for primary ventricular fibrillation during a first myocardial infarction: Clinical findings from PREDESTINATION (PRimary vEntricular fibrillation and suDden dEath during firST myocardIal iNfArcTION) 99
Effects of Intra-Aortic Balloon Pump on Markers of Right Ventricular Dysfunction Among End-Stage Heart Failure Patients Candidates to Cardiac Transplant or Ventricular Assist Device 98
Clinical management of catecholaminergic polymorphic ventricular tachycardia the role of left cardiac sympathetic denervation 98
Early Complete Revascularization in Hemodynamically Stable Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease 98
Protective effect of vagal stimulation on reperfusion arrhythmias in cats. 96
Torsades de Pointes following Acute Myocardial Infarction: Evidence for a Deadly Link with a Common Genetic Variant. 96
Autonomic reflexes and ventricular tachycardia. 96
Primum non nocere: An updated meta-analysis on aspirin use in primary prevention of cardiovascular disease in patients with diabetes 96
Extracorporeal membrane oxigenation support decreases mortality in acute myocardial infarction complicated by refractory cardiogenic shock 95
Has hyperglycemia a different prognostic role in STEMI patients with or without diabetes? 95
Hospital survival and long term quality of life after emergency institution of venoarterial ECMO for refractory circulatory collapse. 94
Significant left ventricular reverse remodelling following radiofrequency ablation of monomorphic ventricular ectopy in pts with idiopathic cardiomyopathy 93
A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study 93
Gene symbol: SCN5A 92
Pharmacologic modulation of the autonomic nervous system in the prevention of sudden cardiac death. A study with propranolol, methacholine and oxotremorine in conscious dogs with a healed myocardial infarction. 92
Chemokines and Heart Disease: A Network Connecting Cardiovascular Biology to Immune and Autonomic Nervous Systems 92
Neutrophil to platelet ratio: a novel prognostic biomarker in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention 92
Calmodulin mutations associated with recurrent cardiac arrest in infants. 90
Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: a prespecified subgroup analysis of the TRA 2°P-TIMI 50 trial 90
Left cardiac sympathetic denervation for the prevention of life-threatening arrhythmias: the surgical supraclavicular approach to cervicothoracic sympathectomy 89
Protective effect of vagal hyperactivity on reperfusion arrhythmias 89
Gene symbol: KCNH2 89
Clinical neurocardiology defining the value of neuroscience-based cardiovascular therapeutics. 88
Sympathetic-parasympathetic interaction in health and disease: abnormalities and relevance in heart failure. 87
Chronic vagus nerve stimulation (CVNS) – A new target for treatment of congestive heart failure. 87
Comparison of antithrombotic strategies in patients with cryptogenic stroke and patent foramen ovale: an updated meta-analysis 87
Identification of upregulated microRNAs in the plasma of patients with acute myocardial infarction 86
Use of extracorporeal membrane oxygenation in primary refractory cardiac shock and cardiac arrest; a single centre experience 85
Prevalenza della aritmie atriali nei pazienti sottoposti a trapianto cardiaco ortotopico secondo la tecnica di Lower e Shumway 85
QT interval prolongation related to psychoactive drug treatment: a comparison of monotherapy versus polytherapy. 85
The ALPHA study (T-wave alternans in patients with heart failure): rationale, design and endpoints. 85
Letter by Ferrari et al regarding article, "long-term arrhythmia-free survival in patients with severe left ventricular dysfunction and no inducible ventricular tachycardia after myocardial infarction" 85
The Common Long QT Syndrome mutation KCNQ1/A341V causes unusually severe clinical manifestations in patients with different ethnic backgrounds: toward a mutation-specific risk stratification. 84
IntErnationaL eLeCTRicAl storm registry (ELECTRA): Background, rationale, study design, and expected results 84
Prevalence and features of incessant atrial arrhythmias after heart transplantation with standard technique. 83
Two-to-one AV block associated with the congenital long QT syndrome. 83
Impaired baroreflex sensitivity is correlated with hemodynamic deterioration of sustained ventricular tachycardia. 83
Sympathetic-parasympathetic interaction and accentuated antagonism in conscious dogs 83
High-dose erythropoietin in patients with acute myocardial infarction: a pilot, randomised, placebo-controlled study. 82
Usefulness of cardiac magnetic resonance in assessing the risk of ventricular arrhythmias and sudden death in patients with hypertrophic cardiomyopathy 82
Vagal activity and ventricular fibrillation 81
Left cardiac sympathetic denervation for the prevention of life-threatening arrhythmias: the surgical supraclavicular approach to cervicothoracic sympathectomy. 80
Prevention of life-threatening arrhythmias by pharmacologic stimulation of the muscarinic receptors with oxotremorine. 80
Le cicatrici degli interventi chirurgici di compartimentalizzazione atriale possono condurre a distanza dalla procedura? 80
Do increases in markers of vagal activity imply protection from sudden death? The case of scopolamine. 79
Totale 10.847
Salva come PNG Salva come JPEG
Categoria #
all - tutte 80.106
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.106
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022780 0 0 14 14 5 27 9 51 46 16 121 477
2022/20232.402 306 164 22 153 197 216 2 105 1.154 15 48 20
2023/2024898 54 258 24 56 62 248 34 59 6 32 41 24
2024/20252.288 56 236 57 54 37 72 107 151 629 75 242 572
2025/20266.807 479 618 1.007 1.019 748 271 1.068 263 502 456 235 141
2026/2027483 100 333 50 0 0 0 0 0 0 0 0 0
Totale 17.958